ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2020

Conference call and webcast on Tuesday, September 22 at 2:30 pm CET/8:30 am ET

ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today provided a business and financial update.